Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome

Molecular Psychiatry

Volumn 21, Issue 2, 2016, Pages 261-269

  Hornig, M ^a   Gottschalk, G ^b   Peterson, D L ^b   Knox, K K ^c,d   Schultz, A F ^a   Eddy, M L ^a   Che, X ^a   Lipkin, W I ^a,e  

^a Department of Medicine   (United States)

^b Sierra Internal Medicine Associates   (United States)

^c Coppe Healthcare Solutions ^*  (United States)

^d Simmaron Research   (United States)

^e Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; BETA INTERFERON; CD40 LIGAND; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR 2; CYTOKINE; EOTAXIN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; CCL11 PROTEIN, HUMAN;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; TH2 CELL; CASE CONTROL STUDY; CEREBROSPINAL FLUID; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; CASE-CONTROL STUDIES; CHEMOKINE CCL11; CYTOKINES; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 84955203947     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.29     Document Type: Article

References (54)

1. Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 2009; 8: 287-291.
2. Lyall M, Peakman M, Wessely S. A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J Psychosom Res 2003; 55: 79-90.
3. Morris G, Anderson G, Galecki P, Berk M, Maes M. A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior. BMC Med 2013; 11: 64.
4. Komaroff AL, Cho TA. Role of infection and neurologic dysfunction in chronic fatigue syndrome. Semin Neurol 2011; 31: 325-337.
5. White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry 1998; 173: 475-481.
6. Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006; 333: 575.
7. Devanur LD, Kerr JR. Chronic fatigue syndrome. J Clin Virol 2006; 37: 139-150.
8. Lerner AM, Ariza ME, Williams M, Jason L, Beqaj S, Fitzgerald JT et al. Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset. PLoS One 2012; 7: e47891.
9. Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol 2006; 37: S39-S46.
10. Komaroff AL, Jacobson S, Ablashi DV, Yamanishi K. Highlights from 5th International Conference on HHV-6 and-7. Herpes 2006; 13: 81-82.
11. Chapenko S, Krumina A, Kozireva S, Nora Z, Sultanova A, Viksna L et al. Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome. J Clin Virol 2006; 37: S47-S51.
12. Chia J, Chia A, Voeller M, Lee T, Chang R. Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence. J Clin Pathol 2010; 63: 165-168.
13. Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT. IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2 (UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome. In Vivo 2002; 16: 153-159.
14. Beqaj SH, Lerner AM, Fitzgerald JT. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol 2008; 61: 623-626.
15. Carruthers BM, Jain AK, DeMeirleir KL, Peterson DL, Klimas NG, Lerner AM et al. Myalgic Encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatments protocols. J Chr Fatigue Synd 2003; 11: 7-115.
16. Nijs J, Nicolson GL, De Becker P, Coomans D, De Meirleir K. High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. FEMS Immunol Med Microbiol 2002; 34: 209-214.
17. Gustaw K. [Chronic fatigue syndrome following tick-borne diseases]. Neurol Neurochir Pol 2003; 37: 1211-1221.
18. Shungu DC, Weiduschat N, Murrough JW, Mao X, Pillemer S, Dyke JP et al. Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed 2012; 25: 1073-1087.
19. Puri BK, Jakeman PM, Agour M, Gunatilake KD, Fernando KA, Gurusinghe AI et al. Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): a voxel-based morphometry 3 T MRI study. Br J Radiol 2012; 85: e270-e273.
20. Zeineh MM, Kang J, Atlas SW, Raman MM, Reiss AL, Norris JL et al. Right arcuate fasciculus abnormality in chronic fatigue syndrome. Radiology 2014; 274: 517-526.
21. Natelson BH, Weaver SA, Tseng CL, Ottenweller JE. Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin Diag Lab Immunol 2005; 12: 52-55.
22. Baraniuk JN, Casado B, Maibach H, Clauw DJ, Pannell LK, Hess SS. A chronic fatigue syndrome-related proteome in human cerebrospinal fluid. BMC Neurol 2005; 5: 22.
23. Schutzer SE, Angel TE, Liu T, Schepmoes AA, Clauss TR, Adkins JN et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS One 2011; 6: e17287.
24. Schutzer SE, Rounds MA, Natelson BH, Ecker DJ, Eshoo MW. Analysis of cerebrospinal fluid from chronic fatigue syndrome patients for multiple human ubiquitous viruses and xenotropic murine leukemia-related virus. Ann Neurol 2011; 69: 735-738.
25. Knox KK, Carrigan DR. In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J Infect Dis 1992; 165: 925-929.
26. Burd EM, Knox KK, Carrigan DR. Human herpesvirus-6-associated suppression of growth factor-induced macrophage maturation in human bone marrow cultures. Blood 1993; 81: 1645-1650.
27. Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993; 167: 735-739.
28. Gonzalez-Dunia D, Volmer R, Mayer D, Schwemmle M. Borna disease virus interference with neuronal plasticity. Virus Res 2005; 111: 224-234.
29. Wigerius M, Melik W, Elvang A, Johansson M. Rac1 and Scribble are targets for the arrest of neurite outgrowth by TBE virus NS5. Molec Cell Neurosci 2010; 44: 260-271.
30. Hanken K, Eling P, Hildebrandt H. The representation of inflammatory signals in the brain-a model for subjective fatigue in multiple sclerosis. Front Neurol 2014; 5: 264.
31. McDonald WI, Ron MA. Multiple sclerosis: The disease and its manifestations. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1615-1622.
32. Navikas V, Link H. Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 1996; 45: 322-333.
33. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121: 953-959.
34. Martins TB. Development of internal controls for the Luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile. Clin Diag Lab Immunol 2002; 9: 41-45.
35. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000; 243: 243-255.
36. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc Series B 1964; 26: 211-252.
37. Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Series B 1996; 58: 267-288.
38. Smith M, Milic-Frayling N, Shneiderman B, Mendes Rodrigues E, Leskovec J, Dunne C NXL: a free and open network overview, discovery and exploration add-in for Excel 2007/2010. Social Media Research Foundationhttp://www. smrfoundation. org2010. (accessed 1 August 2014) at http://nodexl. codeplex. com/.
39. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 1995; 57: 289-300.
40. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Wadsworth & Brooks/Cole Advanced Books & Software: Monterey, CA, USA 1984.
41. Sevcikova S, Kubiczkova L, Sedlarikova L, Rihova L, Kryukov F, Szturz P et al. Impact of anakinra treatment on cytokine and lymphocytes/monocytes profile of an Erdheim-Chester patient. Klin Onkol 2014; 27: 276-282.
42. Pattaro C, Heinrich J, Werner M, de Marco R, Wjst M. Association between interleukin-1 receptor antagonist gene and asthma-related traits in a German adult population. Allergy 2006; 61: 239-244.
43. Amrol DJ, Hagaman DD, Sheller JR, Murray JJ. Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge. J Asthma 2005; 42: 73-76.
44. Endicott NA. Chronic fatigue syndrome in psychiatric patients: lifetime and premorbid personal history of physical health. Psychosom Med 1998; 60: 744-751.
45. Borish L, Schmaling K, DiClementi JD, Streib J, Negri J, Jones JF. Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables. J Allerg Clin Immunol 1998; 102: 222-230.
46. Sim TC, Hilsmeier KA, Reece LM, Grant JA, Alam R. Interleukin-1 receptor antagonist protein inhibits the synthesis of IgE and proinflammatory cytokines by allergen-stimulated mononuclear cells. Am J Respir Cell Molec Biol 1994; 11: 473-479.
47. Lacey DC, Achuthan A, Fleetwood AJ, Dinh H, Roiniotis J, Scholz GM et al. Defining GM-CSF-and macrophage-CSF-dependent macrophage responses by in vitro models. J Immunol 2012; 188: 5752-5765.
48. Pease JE. Asthma, allergy and chemokines. Curr Drug Targets 2006; 7: 3-12.
49. Lampinen M, Carlson M, Hakansson LD, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004; 59: 793-805.
50. Bisset LR, Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulmon Med 2005; 11: 35-42.
51. Boulware DR, Bonham SC, Meya DB, Wiesner DL, Park GS, Kambugu A et al. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J Infect Dis 2010; 202: 962-970.
52. Chang EE, Yen CM. Eosinophil chemoattracted by eotaxin from cerebrospinal fluid of mice infected with Angiostrongylus cantonensis assayed in a microchamber. Kaohsiung J Med Sci 2004; 20: 209-215.
53. Kielian T. Microglia and chemokines in infectious diseases of the nervous system: views and reviews. Front Biosci 2004; 9: 732-750.
54. Hosking MP, Lane TE. The role of chemokines during viral infection of the CNS. PLoS Pathog 2010; 6: e1000937.